Triptorelin

FDA-approved depot GnRH agonistEstablished

Also known as: Trelstar, Decapeptyl, GnRH agonist

Triptorelin (also called Trelstar or Decapeptyl) is an FDA-approved depot GnRH agonist. Triptorelin is a GnRH agonist decapeptide with a D-tryptophan substitution at position six that increases receptor affinity and resists enzymatic degradation.

Calculate Dose

For research use only.

Key Facts

CAS
57773-63-4
Molecular Weight (MW)
1311.4 g/mol
Half-life
Depot: weeks to months
FDA status
Approved
Administration Route
Intramuscular
Frequency
Monthly to 24-week depot
Last updated
Aug 30, 2026
Reviewed
Aug 30, 2026
Targets
GnRH receptor

Research summary

FDA-approved depot GnRH agonist (Trelstar) for advanced prostate cancer. Causes flare then downregulation of LH/testosterone. WADA S2.

Peptide Library's Triptorelin profile summarises 5 cited studies listed in the Science section, the compound's regulatory status, and research-protocol parameters reported for it. It is a research reference, not medical advice.

Protocol

Dosage Range
Depot 3.75โ€“22.5 mg IM on labeled intervals
Frequency
Monthly to 24-week depot
Cycle
Long-term ADT as prescribed
Administration Route
Intramuscular
Reconstitution Guide
โ€”
Injection Sites
Gluteal
Timing Notes
Educational catalog only โ€” not medical advice

Not yet checked against primary sources

These figures are compiled from earlier reference material. They have not been verified against FDA labelling, registered trials or published literature, no citation is attached to them, and none of them is a recommended dose. Triptorelin is queued for dosage evidence review.

Compare reported doses across the whole library

Sequence & molecular data

Sequence and molecular data for Triptorelin
Molecular formulaC64H82N18O13
Molecular weight1311.4 g/mol
CAS number57773-63-4
Half-lifeDepot: weeks to months
AppearanceLyophilized powder for depot injection
FormulationLyophilized Powder
PubChem CID25074470
FDA UNII9081Y98W2V
ChEMBLCHEMBL1201334
DrugBankDB06825

Identifiers link to the public PubChem, FDA Substance Registration (UNII), ChEMBL and DrugBank records for the same entity.

Science

Mechanism of Action

Triptorelin is a GnRH agonist decapeptide with a D-tryptophan substitution at position six that increases receptor affinity and resists enzymatic degradation. Given as a depot it provides continuous rather than pulsatile receptor occupancy, which first stimulates and then desensitises pituitary gonadotrophs: luteinising and follicle-stimulating hormone rise transiently, then fall as the receptor is downregulated, and gonadal steroid production declines to castrate concentrations over roughly two to four weeks. The same initial flare seen with other GnRH agonists occurs, and formulations are available giving one, three or six months of suppression.

Origin

Synthetic decapeptide GnRH analog.

Targets

GnRH receptor

Regulatory & research status

Triptorelin is an FDA-approved product for specific labelled indications. Approval does not extend to the research contexts described on this page, and approved products are prescription medicines.

Regulatory and research status for Triptorelin
FDA statusApproved
AvailabilityPrescription-Only
WADA (sport)Banned in Sport
Library classificationFDA-Approved

Benefits

Labeled prostate-cancer ADT

Potential Side Effects

Side Effects

  • Hot flashes
  • Bone loss
  • Tumor flare
  • Injection-site reactions

Storage & stability

Lyophilized (freeze-dried) peptide powder is far more stable than the reconstituted solution. Keep sealed vials cold, dry and away from light; long-term storage is typically frozen, with short-term refrigeration for vials in use.

Once reconstituted in bacteriostatic water, keep the solution refrigerated, avoid repeated freezeโ€“thaw cycles and agitation, and label the vial with the reconstitution date and concentration. Discard any solution that turns cloudy or shows particulates.

Degradation rates differ by sequence: peptides containing methionine, cysteine, asparagine or glutamine are more prone to oxidation and deamidation, so shelf life after reconstitution is compound-specific rather than universal.

Read the full guide: how to store peptides before and after reconstitution โ†’

Source: Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544โ€“575. (PMID 20143256). General guidance for research handling; not product-specific instructions.

Triptorelin: frequently asked questions

What is Triptorelin?

FDA-approved depot GnRH agonist (Trelstar) for advanced prostate cancer. Causes flare then downregulation of LH/testosterone. WADA S2.

How does Triptorelin work?

Triptorelin is a GnRH agonist decapeptide with a D-tryptophan substitution at position six that increases receptor affinity and resists enzymatic degradation. Given as a depot it provides continuous rather than pulsatile receptor occupancy, which first stimulates and then desensitises pituitary gonadotrophs: luteinising and follicle-stimulating hormone rise transiently, then fall as the receptor is downregulated, and gonadal steroid production declines to castrate concentrations over roughly two to four weeks.

Is Triptorelin FDA approved?

Yes. Triptorelin is approved by the FDA, and approved products are prescription medicines. Approval is always for specific indications studied in clinical trials, so an approved status does not mean the compound is approved for every use it is discussed for. Research-chemical material sold under the same name is not the approved product.

What is the half-life of Triptorelin?

Reported half-life for Triptorelin is Depot: weeks to months. Half-life describes how long the compound persists in circulation, not how long any effect lasts, and published figures vary with route of administration, formulation and the population studied.

Is Triptorelin banned in sport?

Triptorelin is recorded here as prohibited in sport. Athletes subject to anti-doping rules should check the current WADA Prohibited List directly, since it is revised annually and classifications change.

What peptides are similar to Triptorelin?

Compounds most often compared with Triptorelin include Leuprolide, Goserelin, Nafarelin and Histrelin. They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.

References

Related research, comparisons & guides

Related peptides

Compiled by Peptide Library Editorial ยท Reviewed Aug 30, 2026 ยท Updated Aug 30, 2026 ยท Version 1

This Triptorelin profile is compiled from published literature (5 cited studies linked above), public regulatory records and chemical registries. It describes what research reports; it is not medical advice, and nothing here is a dosing recommendation for humans. Peptide Library does not sell peptides. Editorial policy ยท How profiles are compiled ยท Report an error

Track Triptorelin research, inventory and reconstitution in the free Peptide Library app. Get the app for iOS or Android โ†’